EU/1/07/424/001 |
46872 |
Torisel 30 mg koncentrát a rozpúš?adlo na infúzny roztok |
cif fol 1x1,2 ml/30 mg+1x2,2 ml solv. (liek.inj.skl.) |
PFI-BE-3 |
|
EU/1/13/878/001 |
7772A |
Defitelio 80 mg/ml infúzny koncentrát |
con inf 10x2,5 ml/200 mg (liek.inj.skl.) |
GTI |
22.10.2023 |
EU/1/15/1033/001 |
5800B |
KANUMA 2 mg/ml infúzny koncentrát |
con inf 1x10 ml/20 mg (liek.inj.skl.) |
ALX-1 |
28.08.2020 |
EU/1/17/1214/001 |
5581C |
Bavencio 20 mg/ml infúzny koncentrát |
con inf 1x10 ml/200 mg (liek.inj.skl.) |
MCK-NL |
20.09.2019 |
EU/1/16/1130/001 |
1535C |
ONIVYDE 5 mg/ml infúzny koncentrát |
con inf 1x10 ml/50 mg (liek.inj.skl.) |
BXA |
14.10.2021 |
EU/1/17/1245/003 |
6845C |
PREVYMIS 240 mg koncentrát na infúzny roztok |
con inf 1x12 ml/240 mg (liek.inj.skl.) |
MSD-NL |
08.01.2023 |
EU/1/16/1143/002 |
3989C |
Lartruvo 10 mg/ml infúzny koncentrát |
con inf 1x19 ml/190 mg (liek.inj.skl.) |
LIL-NL-2 |
11.11.2019 |
EU/1/16/1101/002 |
9489B |
DARZALEX 20 mg/ml koncentrát na infúzny roztok |
con inf 1x20 ml/400 mg (liek.inj.skl.) |
JNS |
24.05.2018 |
EU/1/17/1245/004 |
6846C |
PREVYMIS 480 mg koncentrát na infúzny roztok |
con inf 1x24 ml/480 mg (liek.inj.skl.) |
MSD-NL |
08.01.2023 |
EU/1/07/393/001 |
43567 |
Soliris 300 mg infúzny koncentrát |
con inf 1x30 ml/300 mg (liek.inj.skl.) |
ALX-1 |
|
EU/1/17/1191/001 |
3995C |
Qarziba 4,5 mg/1 ml koncentrát na infúzny roztok |
con inf 1x4,5 ml/20 mg (liek.inj.skl.) |
EUS |
08.05.2022 |
EU/1/14/937/001 |
1191B |
Gazyvaro 1 000 mg infúzny koncentrát |
con inf 1x40 ml (liek inj.skl.) |
HLR-DE |
23.07.2019 |
EU/1/18/1301/001 |
9133C |
Mepsevii 2 mg/ml infúzny koncentrát |
con inf 1x5 ml/10 mg (liek.skl.) |
ULT |
23.08.2023 |
EU/1/18/1320/001 |
9532C |
Onpattro 2 mg/ml infúzny koncentrát |
con inf 1x5 ml/10 mg (liek.skl.) |
AYL |
27.08.2023 |
EU/1/16/1101/001 |
9488B |
DARZALEX 20 mg/ml koncentrát na infúzny roztok |
con inf 1x5 ml/100 mg (liek.inj.skl.) |
JNS |
24.05.2018 |
EU/1/14/914/001 |
0258B |
Vimizim 1 mg/ml infúzny koncentrát |
con inf 1x5 ml/5 mg (lie.inj.skl.) |
BAN |
28.04.2019 |
EU/1/10/625/003 |
06207 |
Arzerra 1000 mg infúzny koncentrát |
con inf 1x50 ml/1000 mg (liek.inj.skl.) |
NEH-IE |
21.04.2016 |
EU/1/16/1143/001 |
1991C |
Lartruvo 10 mg/ml infúzny koncentrát |
con inf 1x50 ml/500 mg (liek.inj.skl.) |
LIL-NL-2 |
11.11.2019 |
EU/1/16/1143/003 |
3990C |
Lartruvo 10 mg/ml infúzny koncentrát |
con inf 2x19 ml/190 mg (liek.inj.skl.) |
LIL-NL-2 |
11.11.2019 |
EU/1/10/625/001 |
89034 |
Arzerra 100 mg infúzny koncentrát |
con inf 3x5 ml/100 mg (liek.inj.skl.) |
NEH-IE |
21.04.2016 |
EU/1/16/1110/001 |
3820C |
Chenodeoxycholic acid Leadiant 250 mg tvrdé kapsuly |
cps dur 100x250 mg (PVC/Al) |
LEI |
10.04.2022 |
EU/1/07/422/006 |
03850 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 112(4x28)x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/004 |
46944 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 112(4x28)x200 mg (blis.PA/Al/PVC/Al) púzdro |
NEH-IE |
|
EU/1/07/422/008 |
09720 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 112(4x28)x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/003 |
46943 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 112(4x28)x200 mg (blis.PVC/PVDC/Al) púzdro |
NEH-IE |
|
EU/1/07/422/015 |
7818C |
Tasigna 50 mg tvrdé kapsuly |
cps dur 120 (3x40)x50 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/010 |
11645 |
Tasigna 150 mg tvrdé kapsuly |
cps dur 120(3x40)x150 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/07/422/012 |
11647 |
Tasigna 200 mg tvrdé kapsuly |
cps dur 120(3x40)x200 mg (blis.PVC/PVDC/Al) |
NEH-IE |
|
EU/1/14/945/002 |
2190B |
IMBRUVICA 140 mg tvrdé kapsuly |
cps dur 120x140 mg (f?.HDPE) |
JNS |
21.10.2019 |
EU/1/13/870/006 |
7402A |
Orphacol 250 mg tvrdé kapsuly |
cps dur 120x250 mg (blis.PVC/Al) |
LTR-1 |
12.09.2018 |
EU/1/13/870/003 |
7399A |
Orphacol 50 mg tvrdé kapsuly |
cps dur 120x50 mg (blis.PVC/Al) |
LTR-1 |
12.09.2018 |
EU/1/15/1023/002 |
5848B |
Farydak 10 mg tvrdé kapsuly |
cps dur 12x10 mg (blis.PVC/PCTFE/Al) |
NEH-IE |
28.08.2020 |
EU/1/15/1023/005 |
5855B |
Farydak 15 mg tvrdé kapsuly |
cps dur 12x15 mg (blis.PVC/PCTFE/Al) |
NEH-IE |
28.08.2020 |
EU/1/15/1023/008 |
5864B |
Farydak 20 mg tvrdé kapsuly |
cps dur 12x20 mg (blis.PVC/PCTFE/Al) |
NEH-IE |
28.08.2020 |
EU/1/15/1036/002 |
6527B |
CRESEMBA 100 mg tvrdé kapsuly |
cps dur 14x100 mg (blis.Al/Al) |
BSL-GB-1 |
15.10.2020 |
EU/1/15/1082/001 |
9811B |
Galafold 123 mg tvrdé kapsuly |
cps dur 14x123 mg (blis. PVC/PCTFE/PVC/Al) |
AIU |
26.05.2021 |
EU/1/14/974/003 |
3782B |
Cerdelga 84 mg tvrdé kapsuly |
cps dur 14x84 mg (blis.PETG/COC.PETG/PCTFE-Al) |
GZE |
19.01.2020 |
EU/1/14/974/002 |
2877B |
Cerdelga 84 mg tvrdé kapsuly |
cps dur 196x84 mg (blis.PETG/COC.PETG/PCTFE-Al) |
GZE |
19.01.2020 |
EU/1/13/850/001 |
6541A |
Imnovid 1 mg tvrdé kapsuly |
cps dur 21x1 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/07/391/002 |
43534 |
Revlimid 10 mg tvrdé kapsuly |
cps dur 21x10 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/003 |
43535 |
Revlimid 15 mg tvrdé kapsuly |
cps dur 21x15 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/13/850/002 |
6542A |
Imnovid 2 mg tvrdé kapsuly |
cps dur 21x2 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/07/391/005 |
3077A |
Revlimid 2,5 mg tvrdé kapsuly |
cps dur 21x2,5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/009 |
6549B |
Revlimid 20 mg tvrdé kapsuly |
cps dur 21x20 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/13/890/001 |
9744A |
COMETRIQ 20 mg tvrdé kapsuly |
cps dur 21x20 mg (blis.PVC/PE/PCTFE-Al) |
IAA-1 |
26.03.2019 |
EU/1/13/890/003 |
9746A |
COMETRIQ 20 mg tvrdé kapsuly, COMETRIQ 80 mg tvrdé kapsuly |
cps dur 21x20 mg + 7x80 mg (blis.PVC/PE/PCTFE-Al) |
IAA-1 |
26.03.2019 |
EU/1/07/391/004 |
43536 |
Revlimid 25 mg tvrdé kapsuly |
cps dur 21x25 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/13/850/003 |
6798A |
Imnovid 3 mg tvrdé kapsuly |
cps dur 21x3 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/13/850/004 |
6799A |
Imnovid 4 mg tvrdé kapsuly |
cps dur 21x4 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/07/391/001 |
43533 |
Revlimid 5 mg tvrdé kapsuly |
cps dur 21x5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|